Differences between revisions 7 and 8
Revision 7 as of 2015-10-06 14:46:31
Size: 1773
Editor: aerdemir
Comment:
Revision 8 as of 2015-10-06 14:49:41
Size: 1919
Editor: aerdemir
Comment:
Deletions are marked like this. Additions are marked like this.
Line 40: Line 40:
 * Snehal
  * Go over meshing documentation provided by Craig to evaluate the reproducibility of meshing strategies (with the upgraded Salome).

Recurring Meeting of Cleveland Clinic Core Team

Date: October 6, 2015

Time: 10:30 AM EST

Means: In person meeting

Attendees:

  1. Ahmet Erdemir
  2. Craig Bennetts
  3. Snehal Chokhandre
  4. Robb Colbrunn
  5. Tara Bonner
  6. Will Zaylor

Agenda:

  1. Discuss immediate action items from the last meeting.
  2. Discuss potential publications.
  3. Discuss tissue testing protocol evaluation progress.
  4. Decide immediate action items for the next meeting.
  5. Other.

Immediate Action Items:

  • Ahmet
    • Disseminate joint mechanics testing data for oks004 and oks008.
    • Prepare flowcharts to describe data flow for pre-processing of joint kinematics/kinetics data.
    • Schedule Advisory Board meeting.
  • Craig
    • Explore hexahedral meshing workflows in Salome for STL surfaces.
    • Document in the relevant wiki page convergence of Open Knee(s) - Generation 1 model when using springs.
    • Prepare outline of imaging data manuscript with reference to Scientific Data journal format.
  • Snehal
    • Go over meshing documentation provided by Craig to evaluate the reproducibility of meshing strategies (with the upgraded Salome).

Ongoing Action Items:

  • Craig
    • Anatomical imaging manuscript.
    • Large-scale analysis of simulation parameters for convergence.
  • Snehal
    • Pivot shift manuscript.
    • Cruciate ligament modeling & simulation.

  • Robb
    • Patellofemoral joint experimentation manuscript.
  • Tara
    • Tibiofemoral joint experimentation manuscript.

Notes:

  1. Discuss immediate action items from the last meeting.
    • TBD
  2. Discuss potential publications.
    • TBD
  3. Discuss tissue testing protocol evaluation progress.
    • TBD
  4. Decide immediate action items for the next meeting.
    • TBD
  5. Other.
    • TBD

RecurringMeetings/2015-10-06 (last edited 2016-05-04 22:09:50 by localhost)